SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001387131-20-003816
Filing Date
2020-04-10
Accepted
2020-04-10 09:35:46
Documents
1
Group Members
ALTIUM GROWTH FUND, LPALTIUM GROWTH GP, LLC

Document Format Files

Seq Description Document Type Size
1 ACQUISITION OF BENEFICIAL OWNERSHIP sonn-sc13g_040120.htm SC 13G 145883
  Complete submission text file 0001387131-20-003816.txt   147638
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Subject) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81795 | Film No.: 20786063
SIC: 2834 Pharmaceutical Preparations

Mailing Address 152 W 57 ST FL20 NEW YORK NY 10019
Business Address 152 W 57 ST FL20 NEW YORK NY 10019 2124842711
Altium Capital Management LP (Filed by) CIK: 0001746382 (see all company filings)

IRS No.: 822066653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G